Addressing a Treatment Gap: Rationale for Increasing the Starting Dose of Simvastatin in Hypercholesterolaemic Patients

By Isaacsohn J.  

Clinical Drug Investigation, Vol. 22, Iss. 5, 2002-05 ,pp. : 291-301

Adis International

Access to resources Recommend Favorite

BARIUM: RATIONALE FOR A NEW ORAL REFERENCE DOSE

By Dallas Cham E.   Williams Phillip L.  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 4, Iss. 4, 2001-10 ,pp. : 395-429

Taylor & Francis Ltd

Access to resources Recommend Favorite

Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin

By Ye Yumei   Long Bo   Qian Jinqiao   Perez-Polo Jose   Birnbaum Yochai  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 391-399

Springer Publishing Company

Access to resources Recommend Favorite

Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia

By Filippatos Theodosios D   Elisaf Moses S  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1945-1958

Informa Healthcare

Access to resources Recommend Favorite

Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis

By Pereira Michelly   Cardoso Pablo   Rocha Laurindo   Rêgo Moacyr   Gonçalves Sayonara   Santos Flaviana   Galdino-Pitta Marina   Dantas Andréa   Duarte Ângela   Pitta Maira  

Inflammation Research, Vol. 63, Iss. 4, 2014-04 ,pp. : 309-315

Springer Publishing Company

Access to resources Recommend Favorite